Clinical Trials Logo
  1. Home
  2. Radiofrequency Ablation
  3. NCT05818176

To Improve the Clinical Outcome of Ultrasound-guided Radiofrequency Ablation by NAVIRFA® Navigation System.

Radiofrequency Ablation Clinical Trial

Official title:
To Improve the Clinical Outcome of Ultrasound-guided Radiofrequency Ablation by NAVIRFA® Navigation System.

Clinical Trial Summary

Ultrasonic-guided radiofrequency ablation is the most common minimally invasive treatment for liver cancer. This study will use my country's self-developed intelligent ultrasonic navigation tool (NAVIRFA® Navigation System) to assist in the puncture of the needle during ablation, to observe the operation time, Whether the needle accuracy, ablation effect and complications are different from the traditional free-hand ultrasonic guidance technology.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05818176
Study type Interventional
Source National Taiwan University Hospital
Contact Kai-Wen Huang, MD, PhD
Phone +886-23123456
Email fangyu0429@gmail.com
Status Recruiting
Phase N/A
Start date April 1, 2023
Completion date December 31, 2023
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04420013 - Colorectal Cancer Immunomonitoring Combined With Radiofrequency ablatIon
Completed NCT02382289 - Radiofrequency in Sacroiliac Arthropathy;Bipolar RF 6 Points Versus Monopolar RF at 6 and 3 Points N/A
Terminated NCT06371716 - Ex-vivo Ultrasound Guided Radiofrequency Ablation on Pancreatic Solid Lesions N/A
Terminated NCT03247413 - Post-lesion Administration of Dexamethasone to Prevent the Development of Neuritis After Radiofrequency Ablation Phase 4
Recruiting NCT06033456 - Combining Stellate Ganglion and T2 and T3 Radiofrequency Ablation on Post-mastectomy Complex Regional Pain Syndrome N/A
Not yet recruiting NCT05559073 - Outcomes of Early Referral to Radiofrequency Ablation in Symptomatic Atrial Fibrillation Patients.
Completed NCT05078541 - Radiofrequency Ablation for Warthin's Tumor N/A
Recruiting NCT06003218 - Dexmedetomidine-esketamine for Percutaneous Radiofrequency Liver Ablation N/A
Recruiting NCT05500703 - Brain Regions and Functional Neuronal Network Characteristics of Dexmedetomidine Analgesia Phase 4
Completed NCT05719948 - Combined Continuous and Pulsed Radiofrequency Ablation for Pain Relief and Their Safety in Cervical Facet Pain N/A
Completed NCT03375281 - Radiofrequency Ablation Using Octopus Electrodes for Small Hepatocellular Carcinoma With No-touch Technique N/A
Recruiting NCT05142904 - Radiofrequency Ablation Versus I-131 for Solitary Autonomous Thyroid Nodules Phase 3
Recruiting NCT00750711 - Typical Flutter Ablation:A Comparison of 4 mm Versus 2 mm Irrigated cathéters N/A
Recruiting NCT02793479 - Radiofrequency Ablation in Patients With Barrett's Esophagus
Completed NCT01091597 - Pulmonary Vein (PV) Isolation Versus Box Isolation for the Treatment of Atrial Fibrillation N/A
Not yet recruiting NCT04417010 - To Identify KRAS Gene and Safe Margin in Association With Outcome in Colorectal Liver Metastases Following Ultrasound-guided Radiofrequency Ablation
Recruiting NCT03067493 - RFA or Surgical Resection Combined With Neo-MASCT for Primary HCC: a Phase II Trial Phase 2
Recruiting NCT04471272 - RFA Using Gradual RF Energy Delivery Mode With Octopus Electrodes N/A
Recruiting NCT04842253 - HFNC vs LFNC in Patients With AF Undergoing RFCA Under Deep Sedation. N/A
Completed NCT04801719 - Endoluminal Radiofrequency Ablation for the Treatment of Malignant Biliary Stenosis N/A